Geoffrey D. Chisholm

Geoffrey D. Chisholm's AcademicInfluence.com Rankings

Philosophy

#7571

World Rank

#10805

Historical Rank

Logic

#4622

World Rank

#5937

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Geoffrey D. Chisholm's Degrees

Doctorate Medicine University of California, San Francisco
PhD Biomedical Sciences University of California, San Francisco

Why Is Geoffrey D. Chisholm Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Geoffrey D. Chisholm's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Results of conservative management of clinically localized prostate cancer. (1994) (683)
Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group. (1997) (630)
Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients (1996) (337)
Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. (1992) (199)
The natural history of renal carcinoma. (1983) (187)
Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial. (1993) (183)
Changes in urinary cytokines and soluble intercellular adhesion molecule‐1 (ICAM‐1) in bladder cancer patients after Bacillus Calmette—Guérin (BCG) immunotherapy (1995) (161)
Concentration of Antibacterial Agents in Interstitial Tissue Fluid (1973) (149)
Lymphocyte sub-populations in the male genital tract. (1985) (129)
Serum testosterone and dihydrotestosterone changes with age in rat (1975) (128)
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. (1990) (117)
Immunocompetent cells in human testis in health and disease. (1987) (109)
Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer. (1983) (107)
Intra-epithelial lymphocytes in the normal epididymis. A mechanism for tolerance to sperm auto-antigens? (1984) (99)
Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods. (1987) (97)
Prevalence and patterns of spina bifida occulta in 2707 normal adults. (1987) (96)
T.N.M. classification for urological tumours (U.I.C.C.) - 1974. (1975) (93)
HLA-DR expression by high grade superficial bladder cancer treated with BCG. (1989) (86)
Flat carcinoma in Situ of bladder. (1975) (85)
Leucocytes in the ejaculate from fertile and infertile men. (1986) (83)
Morbidity following cystoscopy: comparison of flexible and rigid techniques. (1990) (76)
Bone scanning and plasma phosphatases in carcinoma of the prostate. (1978) (74)
Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour. (1989) (72)
Retroperitoneal Fibrosis Associated with Malignant Disease (1973) (72)
Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy. (1995) (71)
Patterns of bone metastasis and their prognostic significance in patients with carcinoma of the prostate. (1993) (68)
Local immune responses after intravesical BCG treatment for carcinoma in situ. (1987) (65)
Possible airborne spread of serum-hepatitis virus within a haemodialysis unit. (1971) (65)
Bladder dysfunction and neuropathy in diabetes (1976) (62)
The role of multiple mucosal biopsies in the management of patients with bladder cancer. (1979) (60)
SERUM 5α-DIHYDROTESTOSTERONE AND TESTOSTERONE CHANGES WITH AGE IN MAN (1976) (57)
THE SYSTEMIC EFFECTS OF MALIGNANT RENAL TUMOURS1 (1971) (57)
Age, and size and grade of tumour predict prognosis in incidentally diagnosed carcinoma of the prostate. (1988) (55)
Identification of metastatic disease by T category, gleason score and serum PSA level in patients with carcinoma of the prostate. (1992) (53)
Late urinary-tract infection after renal transplantation. (1974) (53)
The Diabetic Bladder (1974) (52)
Basaloid carcinoma of the prostate gland: histogenesis and review of the literature (1992) (51)
Induction of ICAM 1 expression on bladder tumours by BCG immunotherapy. (1994) (50)
Short-term prophylaxis with cefotaxime for prostatic surgery. (1982) (50)
Changes in detrusor innervation with relief of outflow tract obstruction. (1992) (50)
Transitional cell carcinoma involving the prostate. (1981) (48)
TNM (1978) in bladder cancer: use and abuse. (1980) (48)
Incidental carcinoma of the prostate: selection for deferred treatment. (1983) (47)
Prevalence of spina bifida occulta in patients with functional disorders of the lower urinary tract and its relation to urodynamic and neurophysiological measurements. (1989) (46)
The effect of zinc on the 5α-reduction of testosterone by the hyperplastic human prostate gland (1984) (46)
The inhibitory effects of interferon gamma on the growth of bladder cancer cells. (1992) (45)
Production and response of a human prostatic cancer line to transforming growth factor-like molecules. (1990) (44)
Testicular Biopsy in Evaluation of Male Infertility (1973) (44)
Urea Distribution in the Body after Haemodialysis (1962) (44)
Serial bone scanning: the assessment of treatment response in carcinoma of the prostate. (1978) (42)
Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels. (1993) (42)
Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate. (1985) (42)
The dose, distribution, and excretion of gentamicin with speical reference to renal failure. (1969) (41)
The management of bilateral ureteric obstruction and renal failure in advanced prostate cancer. (1994) (40)
Identifying leucocytes and leucocyte subpopulations in semen using monoclonal antibody probes. (1986) (40)
Pathophysiology of tissue fluid. (1972) (39)
Solubilization of human prostatic 5α-reductase (1985) (39)
Benign prostatic hyperplasia: the best treatment. (1989) (39)
Results of surgery following radical radiotherapy for invasive bladder cancer. (1986) (38)
Lymphography and pelvic lymphadenectomy in carcinoma of the prostate. (1976) (38)
Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1. (1992) (37)
Complications of renal transplantation. (1973) (37)
Cis-platin and methotrexate in the treatment of transitional cell carcinoma of the urinary tract. (1985) (36)
The use of methyltrienolone in the measurement of the free and bound cytoplasmic receptors for dihydrotestosterone in benign hypertrophied human prostate. (1978) (36)
NEPHROGENIC RIDGE TUMORS AND THEIR SYNDROMES (1974) (35)
Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases. (1986) (35)
Bacillus-calmette-guerin (bcg) organisms directly alter the growth of bladder-tumor cells. (1994) (35)
A Multicentre Trial to Evaluate Three Treatments for Recurrent Idiopathic Calcium Stone Disease — A Preliminary Report (1985) (34)
Peptic ulceration, gastric secretion, and renal transplantation. (1977) (34)
The Effects of Recombinant Human Intereron-Gamma on a Panel of Human Bladder Cancer Cell Lines (1991) (33)
Failure of human benign prostatic hyperplasia to aromatise testosterone. (1982) (32)
The distribution of PSA, cathepsin‐D, and pS2 in BPH and cancer of the prostate (1992) (32)
Urinary infection and prostatectomy. (1975) (32)
Evidence for the association between blood prolactin and androgen receptors in BPH. (1985) (31)
Primary amyloidosis of the renal pelvis. (1967) (31)
Expression of adhesion molecules by bladder cancer cells: modulation by interferon-gamma and tumour necrosis factor-alpha. (1992) (31)
He sold his bike for a low prostate specific antigen. (1994) (30)
5α‐REDUCTASE ACTIVITY IN HUMAN PROSTATE CANCER IS RELATED TO THE HISTOLOGICAL DIFFERENTIATION OF THE TUMOUR (1985) (30)
Hypertension in patients on regular haemodialysis and after renal allotransplantation. (1969) (29)
The diagnosis of oestrogen escape and the role of secondary orchiectomy in prostatic cancer. (1980) (29)
Urinary Fistulae after Renal Transplantation1 (1973) (28)
Renal angiography problems in live kidney donors. (1978) (27)
18 fluorine total body scans in patients with carcinoma of the prostate. (1971) (27)
The systemic effects of malignant renal tumours. (1971) (27)
The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate. (1977) (26)
The effect of recombinant cytokines on bladder cancer cells in vitro. (1993) (26)
Patterns and significance of the sacral evoked response (the urologist's knee jerk). (1985) (26)
A kinetic analysis of the 5α-reductases from human prostate and liver (1987) (26)
99mTechnetium DMSA and the prediction of recovery in obstructive uropathy. (1981) (26)
Androgen receptors in cancer of the prostate. Correlation with the stage and grade of the tumor (1986) (25)
Androgen metabolism in the epithelial and stromal components of the human hyperplastic prostate. (1981) (25)
Immunohistochemical identification of lymphocyte subsets and macrophages in normal human urothelium using monoclonal antibodies. (1986) (25)
Progress in transrectal ultrasonography for prostatic disease. (1983) (24)
The diagnosis of rejection of renal allotransplants in man. (1969) (24)
Studies with radioactive iodine labelled oestrogens as prostate scanning agents. (1975) (23)
Gastric Acid Secretion in Chronic Uraemia and after Renal Transplantation (1968) (23)
An investigation of factors influencing the in vitro induction of LAK activity against a variety of human bladder cancer cell lines. (1992) (23)
Evidence that human prostatic 5α‐reductase is located exclusively in the nucleus (1985) (23)
Serum dihydrotestosterone in patients with benign prostatic hypertrophy. (1977) (23)
A single injection method for measurement of effective renal plasma flow. (1968) (23)
Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia (1997) (23)
Time to end softly softly approach on harvesting organs for transplantation (1988) (22)
Serial Fluorine-18 bone scans in the follow-up of carcinoma of the prostate. (1975) (22)
Control of leucocyte function-associated antigen-1-dependent cellular conjugation by divalent cations. (1994) (22)
Social class and carcinoma of the prostate. (1979) (22)
Can angiography stage renal carcinoma? (1977) (21)
Gamma-camera renography using 123I-hippuran. (1973) (21)
Stone screening and follow-up are necessary? (1975) (21)
Radiozinc uptake and scintiscanning in prostatic disease. (1974) (21)
A case for synchronous reduction of testicular androgen, adrenal androgen and prolactin for the treatment of advanced carcinoma of the prostate. (1995) (21)
The significance of serum sperm-agglutinating antibodies in men with infertile marriages. (1980) (21)
A randomized trial of 48 hours of prophylactic cefotaxime versus single dose in transurethral prostatic surgery. (1984) (21)
Characterization of the prolactin receptor in human prostate. (1983) (21)
De-differentiation with time in prostate cancer and the influence of treatment on the course of the disease. (1990) (21)
Complete non-puerperial uterine inversion as a result of a uterine sarcoma. (2000) (21)
The effect of testosterone on the human prostate in organ culture. (1973) (20)
Primary vesico-ureteric reflux in adults. (2008) (20)
Lymphocyte subsets in renal carcinoma--a sequential study using monoclonal antibodies. (1984) (20)
Measurement of glomerular filtration-rate using 131-I-diatrizoate. (1969) (19)
Studies of testicular and epididymal damage in relation to the occurrence of antisperm antibodies. (1982) (19)
Ultrasound as an alternative to intravenous urography in prostatism. (1987) (19)
Factors influencing early function of cadaver renal transplants. (1969) (19)
MANNITOL AND RENAL FUNCTION IN CARDIOVASCULAR SURGERY. (1964) (18)
In-Situ Carcinoma of the Urinary Bladder (1970) (18)
Neurophysiological measurements in primary adult enuretics. (1985) (18)
Neurophysiological measurement of the voiding reflex arcs in patients with functional disorders of the lower urinary tract. (1987) (18)
A radiofrequency method of thermal tissue ablation for benign prostatic hyperplasia. (1995) (18)
The quantitative analysis of renograms using the gamma camera. (1970) (18)
Distribution of Gentamicin in Body Fluids (1968) (18)
Receptor proteins for androgens in prostatic disease. (1978) (17)
Hypertension due to hypernephroma. (1969) (17)
Conservative management with symptomatic treatment and delayed hormonal manipulation is justified in men with locally advanced carcinoma of the prostate. (1994) (17)
Prostate cancer screening: accepting the consequences of PSA testing. (1993) (17)
Management of renal carcinoma--a questionnaire survey. (1983) (17)
Towards a reproducible method of estimating androgen receptors in human prostate. (1983) (17)
Treatment of advanced cancer of the prostate. (1985) (16)
Natural history of prostate cancer (1993) (16)
Acquired cystic disease of the kidney: an indication for renal transplantation? (1986) (16)
The measurement of individual renal plasma flows using 123I-hippuran and the gamma camera. (1974) (16)
Measurement of effective renal plasma-flow by the clearance of 125-I-hippuran. (1967) (15)
Intravesical Evans Bacille Calmette-Guérin in the treatment of carcinoma in situ. (1989) (15)
Audit and its impact in the management of early prostatic cancer. (1993) (14)
The effects of recombinant human interferon-gamma on a panel of human bladder cancer cell lines. (1991) (14)
Clinical evaluation of the urinary sediment after renal allotransplantation (1970) (14)
Neurophysiological measurements in patients with genuine stress incontinence of urine and the relation of neurogenic defects to the presence of spina bifida occulta. (1988) (14)
Characterization of the retinol and retinoic acid binding proteins in the human prostate. (1984) (14)
The effect of antiandrogens and stilboestrol on the cytosol receptor in rat prostate. (1977) (14)
Immunopathological effects of intravesical BCG therapy. (1989) (14)
The stable state is not an objective response in hormone-escaped carcinoma of prostate. (1984) (14)
The effect of zinc on the 5 alpha-reduction of testosterone by the hyperplastic human prostate gland. (1984) (14)
Prognostic factors in superficial bladder cancer. (1986) (14)
Radical radiotherapy with salvage surgery for invasive bladder cancer: results following a reduction in radiation dose. (1992) (14)
Levels of circulating intercellular adhesion molecule-1 in patients with metastatic cancer of the prostate and benign prostatic hyperplasia. (1995) (14)
Neurophysiological abnormalities in genuine female stress urinary incontinence (1988) (13)
The bone scan as a tumour marker in prostatic carcinoma. (1982) (13)
Is the incidence of renal carcinoma increasing? (1984) (13)
The immunomodulatory effects of urine from patients with superficial bladder cancer receiving intravesical evans BCG therapy (2005) (13)
MALIGNANT OBSTRUCTIVE URÆMIA1 (1968) (13)
Radical radiotherapy for localized adenocarcinoma of the prostate. A report of 191 cases. (1995) (13)
Maldescended testes and fertility: a review of 68 cases. (1984) (13)
Shared care between general practitioners and urologists in the management of benign prostatic hyperplasia: a survey of attitudes among clinicians. (1995) (13)
The ultrastructure of the male and female prostate of Praomys (Mastomys) natalensis (1978) (13)
Identification of an androgen receptor in the cytosol of the female Mastomys prostate (1977) (12)
TNM classification of urological tumours in 1988. (1988) (12)
Absence of 5 alpha-reductase activity in the gubernaculum during descent of the fetal pig testis. (1993) (12)
Identification of a prostate in female praomys (Mastomys) natalensis using 3-H steroids. (1975) (12)
Factors affecting the reproducibility of androgen receptor determinations in human prostate. (1983) (12)
Hypercalcaemia from calcium ion-exchange resin in patients on regular haemodialysis. (1968) (12)
The detection and prediction of acute rejection episodes in human renal transplants using radioactive fibrinogen. (1973) (12)
Sacral reflex latency in acute retention in female patients. (1987) (12)
Symptomatology of metastatic prostate cancer: prognostic significance. (1994) (12)
Intra-operative myocardial ischaemia detected by biplane transoesophageal echocardiography during transurethral prostatectomy. (1993) (11)
Measures of mortality in prostatic cancer. (1990) (11)
Differential androgen uptake by the lobes of the rhesus monkey prostate. (1977) (11)
Handbook on benign prostatic hyperplasia (1994) (11)
Prostatic lymphoscintigraphy. (1979) (11)
Unilateral Renal Hemodynamic Changes with Hypertonic Mannitol.∗ (1963) (11)
Phaeochromocytomas of the Bladder (1982) (11)
Antibiotic prophylaxis for prostatic surgery. Single-dose cephradine compared with single-dose cefotaxime. (1987) (11)
The Scribner Arteriovenous Fistula for Haemodialysis (1961) (11)
The nonsurgical treatment of prostatic carcinoma. (1975) (10)
Concentration ofAntibacterial Agents inInterstitial Tissue Fluid (1973) (10)
Transitional cell carcinoma in situ. (1986) (10)
Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia (2004) (10)
RELATIONSHIPS BETWEEN SPERMATOGENESIS AND SERUM HORMONE LEVELS IN SUBFERTILE MEN (1977) (10)
THE HORMONE RESPONSE TO A SYNTHETIC ANDROGEN (MESTEROLONE) IN OLIGOSPERMIA (1977) (10)
Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group. (1995) (10)
5alpha-dihydrotestosterone stimulation of human prostate in organ culture. (1975) (9)
Air insufflation versus water irrigation during flexible cystoscopy: a prospective randomized study. (1994) (9)
Androgen concentrations in prostate and serum of the male and female Praomys (Mastomys) natalensis. (1977) (9)
An arteriovenous fistula in a polycystic kidney: a cause of acute renal failure and hematuria. (1966) (9)
DMSA scan and the prediction of recovery in obstructive uropathy. (1982) (9)
99m Technetium DMSA and the Prediction of Recovery in Obstructive Uropathy (1982) (9)
Bladder cancer flow cytometry profiles in relation to histological grade and stage. (1987) (9)
Management options for painful carcinoma of the prostate. (1993) (9)
Inhibition of the nuclear dihydrotestosterone receptor complex from rat ventral prostate by antiandrogens and stilboestrol (1978) (9)
The Burch Colposuspension operation for stress urinary incontinence. (1990) (9)
Receptor protein for dihydrotestosterone in nuclei of the female prostate of Praomys (Mastomys) natalensis. (1978) (8)
Neoadjuvant chemotherapy with methotrexate and cisplatin prior to radiotherapy for invasive transitional cell carcinoma of the bladder. Assessment of feasibility and toxicity. (1991) (8)
EFFECT OF MANNITOL ON RENAL FUNCTION DURING CARDIOVASCULAR SURGERY. (1963) (8)
Antimicrobial prophylaxis in urology and transplantation (1982) (8)
Cytokine modulation of epidermal growth factor receptor expression on bladder cancer cells is not a major contributor to the antitumour activity of cytokines. (1995) (8)
The tissue cage model in the distribution of antibacterial agents. (1978) (8)
Solubilization of human prostatic 5 alpha-reductase. (1985) (8)
The role of growth factors in the human prostate. (1991) (7)
DNA/RNA ratio in bladder cancer: a factor indicating the recurrence rate? (1985) (7)
Nuclear retinoic acid binding protein in human prostate adenomas. (1985) (7)
Urine-urea-blood-urea ratios in renal failure. (1966) (7)
Flow cytometric analysis of cellular DNA in human prostate cancer: relationship to 5α-reductase activity of the tissue (2004) (7)
The distribution of 5α-reductase and 3α(ß)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate gland. (1983) (7)
The bone scan as a monitor of prostatic cancer. (1980) (7)
Prostatectomy: Past and Present (1983) (7)
Intracellular localisation of 5α-dihydrotestosterone in human benign prostatic hypertrophy (1976) (7)
Investigations into the use of 77Br labelled 5α-dihydrotestosterone for scanning the prostate (1977) (7)
Neurological defects of the voiding reflex arcs in chronic urinary retention and their relation to spina bifida occulta. (1989) (6)
Rectovesical fistula secondary to prostatic carcinoma. (1979) (6)
The TNM system of 1992. Comments from the TNM working group. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. (1994) (6)
Obstructive nephropathy. Functional abnormalities and clinical presentation. (1970) (6)
Observations on the ultrastructure of human urothelium: The response of normal bladder of elderly subjects to hyperthermia (2004) (6)
Prognostic value of raised prostatic acid phosphatase and negative skeletal scintigraphy in prostatic cancer. (1991) (6)
Cystometrography provides a previously unrecognized opportunity for successful management of urinary leaks after renal transplantation. (1994) (5)
Androgen receptors in the prostate of the Rhesus monkey (2004) (5)
Treatment of benign prostatic hyperplasia: Author's reply (1989) (5)
Interaction between prolactin and zinc in the human prostate gland. (1984) (5)
Malignant obstructive uraemia. (1968) (5)
The use of radioactive fibrinogen for detecting rejection of human renal transplant. (1972) (5)
Intravesical methotrexate in the treatment of superficial bladder cancer. (1984) (5)
The response of the malignant prostate to endocrine treatment (1983) (5)
Factors influencing the distribution of antibacterial agents in interstitial tissue fluid: Molecular size and protein binding (1976) (5)
Antimicrobial prophylaxis in urology and transplantation. (1982) (5)
Expression of interferon-γ receptors on bladder cancer cells: does it correlate with biological response? (2004) (5)
The quantitation of renal blood flow using I-125 hippuran. An experimental study in the perfusion of the isolated canine kidney. (2008) (4)
Cystic disease of renal pyramids (medullary sponge kidney). (2008) (4)
Urinary fistulae after renal transplantation. (1973) (4)
Proceedings: Serum androgens in male and female Praomys (Mastomys) natelensis. (1976) (4)
Bilateral Renal Clearance Studies in Experimental Obstructive Uropathy (1964) (4)
Blood-potassium in patients undergoing haemodialysis. (1969) (4)
Comparison of radioimmunoassay and immunoradiometric assay for serum prostatic acid phosphatase. (1986) (4)
Prediction of response to radiotherapy for localised prostatic cancer. (1985) (4)
A comparison of retinol binding in human hyperplastic and malignant prostate. (1985) (4)
A soluble androgen receptor in the cytoplasm of the male mastomys prostate (2004) (4)
Uptake and distribution of 3H testosterone in tissues of male Praomys (Mastomys) Natalensis (1976) (4)
Follow-up of prostate carcinoma with serial bone scanning using cyclotron-produced 18-fluorine. (1977) (4)
Pubic ectopic testicle. (1980) (4)
Serum 5alpha-dihydrotestosterone and testosterone changes with age in man. (1976) (4)
The use of 123I labelled oestradiol in detecting the human prostate using a gamma camera (1976) (4)
A kinetic analysis of the 5 alpha-reductases from human prostate and liver. (1987) (3)
Perspectives and Prospects (1981) (3)
Evaluation of the Hg197 chlormerodrin kidney scan. (1967) (3)
The role of endoscopic treatment after radical radiotherapy for invasive bladder cancer. (1985) (3)
Tumour markers in testicular tumours. (1985) (3)
Audit and its impact in the management of advanced prostatic cancer. (1993) (3)
Monoclonal antibodies to human T lymphocyte surface antigens: Their potential application to urology (2004) (3)
Androgen Receptors in Prostatic Cancer (1980) (3)
Bladder Cancer Flow Cytometry Profiles in Relation to Histological Grade and Stage (1988) (3)
Comparison of Bolton-Hunter and Chloramine-T Techniques for the Radioiodination of Prostatic Acid Phosphatase (1983) (3)
LOCALISED PROSTATIC CANCER (1989) (3)
Indications for investigation of post-micturition dribble in young adults. (1987) (3)
Renal Transplantation (1973) (2)
Is the outcome of conservative management for localized prostate cancer acceptable? An overview. (1993) (2)
Nuclear androgen receptors in the prostate of male Praomys (Mastomys) Natalensis (1979) (2)
The effect of anaesthesia and surgery for benign disease of the upper urinary tract on circulating leucocyte subpopulations identified with monoclonal antibodies (2004) (2)
Influence of surgical techniques on receptor levels and 5α‐reductase activity of the human prostate gland (1985) (2)
Conservative treatment of cancer of the prostate (1974) (2)
Hypertension in pyelonephritis. (1968) (2)
Prostate cancer. Nuclear medicine. (1981) (2)
Recent Results in Cancer Research: Volume 78: Prostate Cancer, W. Duncan (Ed.). Springer-Verlag (1981) (1982) (2)
The preparation, characterization and application of monoclonal antibodies to human prostatic acid phosphatase (PAP). (1984) (2)
Malignant disease of the kidney. An appraisal of diagnosis and management. (1974) (2)
The distribution of 5 alpha-reductase and 3 alpha(beta)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate gland. (1983) (2)
Percutaneous and Interventional Urology and Radiology (1986) (2)
Evidence that human prostatic 5 alpha-reductase is located exclusively in the nucleus. (1985) (2)
Benign prostatic hyperplasia: the incidence of prostatectomy within and without Europe. (1994) (2)
The Effect of Embolisation/Nephrectomy for Renal Carcinoma on the Paraneoplastic Syndromes (1983) (1)
In situ carcinoma of the bladder (1980) (1)
Carcinoma of the Prostate — The Need for a Revision of Category to? (1983) (1)
Proceedings: Age-related changes in serum 5alpha-dihydrotestosterone and testosterone in normal men. (1975) (1)
Kidney Scanning: The Clinical Use of 197Hg Chlormerodrin and 99m Tc Iron Complex (1967) (1)
Prostatic cancer. (1976) (1)
Chemotherapy for prostate cancer. Present concerns and future considerations. (1990) (1)
Is the Incidence of Renal Cell Carcinoma Increasing (1985) (1)
Clearance of isotopes from implanted tissue capsules. (1971) (1)
Influence of Surgical Techniques on Receptor Levels and 5α-Reductase Activity of the Human Prostate Gland (1986) (1)
5000 SUBMISSIONS TO THE BRITISH JOURNAL OF UROLOGY (1993) (1)
Prognostic Significance of Biopsy Results of Normal-Looking Mucosa in Cases of Superficial Bladder Cancer (1984) (1)
Benign prostatic hyperplasia. (1992) (1)
Unilateral nephrectomy and hypertension. (1973) (1)
Management of Metastatic Renal Carcinoma (1975) (1)
Prognostic Significance of Biopsy Results of Normal-Looking Mucosa in Cases of Superficial Bladder Cancer (1984) (1)
RENAL PLASMA-FLOW (1967) (1)
Significance of immediate diuresis in relation to transplant kidney survival rate (2005) (1)
An external counting method for measurement of glomerular filtration rate. (1969) (1)
Gastric acid production in chronic uremia and following renal transplantation. (1968) (1)
[Vesico-ureteral reflux in adults]. (1970) (1)
A Comparison of Cyclosporin versus Azathioprine Treatment in Renal Transplants in Edinburgh (1989) (1)
Renal tissue levels of gentamicin and a dose schedule in renal impairment. (1969) (1)
Incidental carcinoma of the prostate (1992) (1)
Talampicillin in the Treatment of Acute Infection in Hospital Practice (1979) (1)
SOLUTE AND WATER EXCRETION IN OBSTRUCTIVE UROPATHY. (1963) (1)
Urodynamic evaluation of lower urinary tract dysfunction. (1972) (1)
Renal lymphatics and urinary tract obstruction. (1967) (1)
10. Carcinoma of the prostate: endocrine aspects of aetiology (1979) (0)
Lymphatic Surgery (1972) (0)
Palliation of pain in bony metastases. (1993) (0)
Intracellular localisation of 5alpha-dihydrotestosterone in human benign prostatic hypertrophy. (1976) (0)
Genitourinary Cancer (1985) (0)
Results of Surgery Following Radical Radiotherapy for Invasive Bladder Cancer (1987) (0)
T Category in Renal Carcinoma (1980) (0)
Diagnosis, management and follow-up of patients with bladder cancer (1978-1979). A multidisciplinary approach. (1983) (0)
Mr W. Keith Yeates, MD. (1992) (0)
Urinary obstruction and dehydration. (1972) (0)
[Onset of and survival in adenocarcinoma of the prostate. Analysis of 48 consecutive cases studied over 10 years]. (1989) (0)
Hypertension in pyelonephritis. (1968) (0)
EXTRACT of SAW PALMETTO for TREATMENT of SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (1998) (0)
Urogenital tract, oncology, and the urological armamentarium (1976) (0)
Bladder cancer: treatment of carcinoma in situ. (1984) (0)
Book Review: The Prostatic Cell: Structure and Function (1982) (0)
A Urodynamic and Neurophysiological Evaluation of the Urethral Sphincter in Multiple Sclerosis (1987) (0)
Book Review: Ureteral Dynamics (1973) (0)
Bloodpotassium in patients undergoing haemodialysis. (1969) (0)
Book Review: Uremia (1972) (0)
Drugs acting on the urinary tract (1982) (0)
Dialysis for renal failure in children. (1967) (0)
Hyperthermia and Bladder Cancer (1980) (0)
Surgical Treatment of Benign Prostatic Hyperplasia: Emergence of Alternatives (1995) (0)
Paraneoplastic syndromes: introduction. (1982) (0)
Ureteric transplantation. Today. (1978) (0)
Prostate cancer. (1992) (0)
Lymph node dissection, renal artery embolization and other aspects of the management of renal carcinoma. (1984) (0)
Induction ofICAM 1expression on bladder tumoursbyBCG immunotherapy (1994) (0)
Management of metastatic renal carcinoma. Surgical aspects. (1975) (0)
Proceedings: The value of urodynamics in the differential diagnosis of urinary outflow tract obstruction. (1974) (0)
A preliminary investigation of temperature distribution in the prostatic urethra during Thermex II thermotherapy (2004) (0)
Characterization of the Retino! and Retinoic Acid Binding Proteins in the Human Prostate1 (2006) (0)
Complications of urologic surgery: Prevention and management. Edited Robert B. Smith and Donald G. Skinner. 250 × 770 mm. Pp. 520 + xiii. Illustrated. 1976. Philadelphia: Saunders. £24·25 (1977) (0)
Conservative treatm.ent of cancer of the prostate (1974) (0)
Refresher Course in Urology (1971) (0)
Intra-renal effects of urinary tract obstruction. (1972) (0)
Prostatic cancer: endocrine treatment. (1984) (0)
Developments in urological surgery 1955--1980. (1980) (0)
Obstructive Nephropathy [Abridged] (1970) (0)
Book reviews (2005) (0)
Book Review: Clinical Renography (1972) (0)
Proceedings: Long-term follow-up of fluorine-18 bone scans in carcinoma of the prostate. (1974) (0)
24 Prolactin receptors in human prostate (1983) (0)
Prostate cancer. Perspectives and prospects. (1981) (0)
Chemotherapy for Prostate Cancer (1990) (0)
Treatment of invasive bladder cancer (lymph node negative, metastases negative). (1989) (0)
Distribution and dosage of antibacterial agents in patients with normal and impaired renal function. (1970) (0)
CORRIGENDUM (1977) (0)
Prostatic cancer: prognostic criteria. (1984) (0)
Prediction of Response to Radiotherapy for Localised Prostatic Cancer (1986) (0)
37. Androgen receptors: New approach for optimising receptor levels in the human prostate (1982) (0)
Preventing casualty wound infection. (1976) (0)
Cancer of the Kidney: Staging (1983) (0)
Critical Review (1989) (0)
Urinary Diversion (1982) (0)
Book Review: Urologic Cancer: A Multidisciplinary Perspective (1985) (0)
Prostatic Cancer: Clinical Significance of Receptor Studies (1983) (0)
The use of gentamicin in urinary tract infections with special reference to drug levels in complicated (urological) infections. (1974) (0)
Obstructive uropathy--a review of 146 patients with postrenal uraemia. (1967) (0)
Urodynamics in the Diagnosis of Outflow Tract Obstruction (1975) (0)
The Prostatic Cell: Structure and Function: Progress in Clinical and Biological Research, vol 75A & B. (1982) (0)
29 Nuclear Androgen Receptor Determination in Human Prostate (1983) (0)
Urology and Renal Medicine J. E. Newsam, Edinburgh, J. J. B. Petrie, Brisbane. Second edition. 185 × 120 mm. Pp. 267 + ix, with 71 illustrations. 1975. Edinburgh: Churchill Livingstone. £2.25 (1975) (0)
Renal disorders, infections, and calculi (1976) (0)
Characterization and measurement of an androgen receptor protein in the cytosol of rhesus monkey prostate [proceedings]. (1977) (0)
Book Review: Transurethral Resection (1972) (0)
Audiovisual review (1986) (0)
[Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate]. (1984) (0)
Significance of symptoms and urodynamics in outflow tract obstruction. (1984) (0)
Carcinoma of the prostate: reasons for endocrine treatment prior to symptomatic metastases. (1990) (0)
Renal stones: screening tests. (1984) (0)
Patterns and Significance of the Sacral Evoked Response (the Urologist’s Knee Jerk) (1985) (0)
The ascent of andrology (1982) (0)
Clinical Renography, K.E. Britton, N.J.G. Brown. Lloyd-Luke, Philadelphia (1971), Price, £0·00 (1972) (0)
Cancer of the prostate: advances in diagnosis and treatment. Report of a round table discussion held at the Third Congress of the European Association of Urology, Monte Carlo, June 16, 1978. (1980) (0)
The Role of Endoscopic Treatment After Radical Radiotherapy for Invasive Bladder Cancer (1986) (0)
Urologic Cancer: A Multidisciplinary Perspective (1985) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Geoffrey D. Chisholm?

Geoffrey D. Chisholm is affiliated with the following schools: